
PUBLICATIONS
Alzheimer’s Disease
2021
Wiesman, A. I., Mundorf, V. M., Casagrande, C. C., Wolfson, S. L., Johnson, C. M., May, P. E., Murman, D. L., & Wilson, T. W. (2021). Somatosensory dysfunction is masked by variable cognitive deficits across patients on the Alzheimer's disease spectrum. EBioMedicine, 73:103638
Wiesman, A. I., Murman, D. L., May, P. E., Schantell, M., Losh, R. A., Johnson, H. J., Willet, M. P., Eastman, J. A., Christopher-Hayes, N. J., Knott, N. L., Houseman, L. L., Wolfson, S. L., Losh, K. L., Johnson, C. M., & Wilson, T. W. (2021). Spatio-spectral relationships between pathological neural dynamics and cognitive impairment along the Alzheimer's disease spectrum. Alzheimer’s & Dementia, 13(1):e12200
Wiesman, A. I., Murman, D. L., May, P. E., Schantell, M., Wolfson, S. L., Johnson, C. M., & Wilson, T. W. (2021). Visuospatial alpha and gamma oscillations scale with the severity of cognitive dysfunction in patients on the Alzheimer's disease spectrum. Alzheimer’s Research & Therapy, 13(1):139
2022
Casagrande, C. C., Wiesman, A. I., Schantell, M., Johnson, H. J., Wolfson, S. L., O'Neill, J., Johnson, C. M., May, P. E., Swindells, S., Murman, D. L., & Wilson, T. W. (2022). Signatures of somatosensory cortical dysfunction in Alzheimer's disease and HIV-associated neurocognitive disorder. Brain Communications, 4(4), fcac169
Springer, S. D., Wiesman, A. I., May, P. E., Schantell, M., Johnson, H. J., Willett, M. P., Castelblanco, C. A., Eastman, J. A., Christopher-Hayes, N. J., Wolfson, S. L., Johnson, C. M., Murman, D. L., & Wilson, T. W. (2022). Altered visual entrainment in patients with Alzheimer's disease: magnetoencephalography evidence. Brain Communications, 4(4), fcac198
Springer, S. D., Wiesman, A. I., May, P. E., Schantell, M., Johnson, H. J., Willett, M. P., Castelblanco, C. A., Eastman, J. A., Christopher-Hayes, N. J., Wolfson, S. L., Johnson, C. M., Murman, D. L., & Wilson, T. W. (2022). Altered visual entrainment in patients with Alzheimer's disease: magnetoencephalography evidence. Brain Communications, 1;4(4), fcac198
Schantell, M., Christopher-Hayes, N. J., Johnson, H. J., Willett, M. P., Wolfson, S. L., Losh, K. L., Johnson, C. M., May, P. E., & Wilson, T. W. (2022). Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease. Brain: A Journal of Neurology, 145(6), 2177–2189
Wiesman, A. I., Murman, D. L., Losh, R. A., Schantell, M., Christopher-Hayes, N. J., Johnson, H. J., Willett, M. P., Wolfson, S. L., Losh, K. L., Johnson, C. M., May, P. E., & Wilson, T.W. (2022). Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease. Brain 145(6):2177-2189
2023
Casagrande, C. C, Rempe, M. P., Springer, S. D., & Wilson, T. W. (2023). Comprehensive review of task-based neuroimaging studies of cognitive deficits in Alzheimer’s Disease using electrophysiological methods. Ageing Research Reviews, 88, 101950
Christopher-Hayes, N.J., Embury, C.M., Wiesman, A.I., May, P.E., Schantell, M., Johnson, C.M., Wolfson, S.L., Murman, D.L., & Wilson, T. W. (2023). Piecing it together: atrophy profiles of hippocampal subfields relate to cognitive impairment along the Alzheimer’s Disease spectrum. Front Aging Neuroscience 15:121297
Horne, L. K., Schantell, M., Mansouri, A., Springer S. D., Wiesman, A. I., Johnson, H. J., Okelberry, H. J., May, P. E., & Wilson, T. W. (2023). A - 23 neuropsychological assessments are highly predictive of B-amyloid positive Alzheimer’s Disease. Archives of Clinical Neuropsychology, 38(7), 1185
Meehan, C. E., Schantell, M., Wiesman, A. I., Wolfson, S. L., O'Neill, J., Bares, S. H., Johnson, C. M., May, P. E., Murman, D. L., & Wilson, T. W. (2023). Oscillatory markers of neuroHIV-related cognitive impairment and Alzheimer's Disease during attentional interference processing. Aging, 15(2), 524–541
Meehan, C. E., Embury, C. M., Wiesman, A. I., Schantell, M., Wolfson, S. L., O'Neill, J., Swindells, S., Johnson, C. M., May, P. E., Murman, D. L., & Wilson, T. W. (2023). Convergent and divergent oscillatory aberrations during visuospatial processing in HIV-related cognitive impairment and Alzheimer's Disease. Cerebral Cortex (New York, N.Y. :1991), 33(6), 3181–3192
Meehan, C. E., Schantell, M., Springer, S. D., Wiesman, A. I., Wolfson, S. L., O'Neill, J., Murman, D. L., Bares, S. H., May, P. E., Johnson, C. M., & Wilson, T. W. (2023). Movement-related beta and gamma oscillations indicate parallels and disparities between Alzheimer’s Disease and HIV-associated neurocognitive disorder. Neurobiology of Disease, 186, 106283
Rempe, M. P., Wiesman, A. I., Murman, D. L., May, P. E., Christopher-Hayes, N. J., Wolfson, S. L., Johnson, C. M., & Wilson, T. W. (2023). Sleep quality differentially modulates neural oscillations and proteinopathy in Alzheimer's Disease. EBioMedicine, 92, 104610
Springer, S. D., Erker, T. D., Schantell, M., Johnson, H. J., Willett, M. P., Okelberry, H. J., Rempe, M. P., & Wilson, T. W. (2023). Disturbances in primary visual processing as a function of healthy aging.NeuroImage, 271, 120020
2024
Petro, N. M., Webert, L. K., Springer, S. D., Okelberry, H. J., John, J. A., Horne, L. K., Glesinger, R., Rempe, M. P., & Wilson, T. W. (2024).
Optimal gamma-band entrainment of visual cortex. Human Brain Mapping; 45(10):e26775
Qu, G., Orlichenko, A., Wang, J., Zhang, G., Xiao, L., Zhang, K., Wilson, T. W., Stephen, J. M., Calhoun, V. D., & Wang, Y. P. (2024).
Interpretable cognitive ability prediction: A comprehensive gated graph transformer framework for analyzing function brain networks. IEEE Transactions on Medical Imaging; 43(4):1568-1578
Son, J. J., Arif, Y., Oludipe, D., Weyrich, L., Killanin, A. D., Wiesman, A. I., Okelberry, H. J., Willett, M. P., Johnson, H. J., & Wilson, T. W. (2024).
Multispectral brain connectivity during visual attention distinguishes controlled from uncontrolled hypertension. Journal of Physiology; 602(8):1775-1790
Wiesman, A. I., Gallego-Rudolf, J., Villeneuve, S., Baillet, S., Wilson, T. W., PREVENT-AD Research Group (2024).
Alignments between clinical neurochemical systems, proteinopathy and neurophysiological alterations along the Alzheimer’s disease continuum. medRxiv Preprint